Evidence map›Paper›PMID 28350803›Full record

ArticlePLoS biology2017

Pharmacogenomic identification of small molecules for lineage specific manipulation of subventricular zone germinal activity.

Kasum Azim, Diane Angonin, Guillaume Marcy, Francesca Pieropan, Andrea Rivera, Vanessa Donega, Claudio Cantù, Gareth Williams, Benedikt Berninger, Arthur M Butt and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Myelin Repair: From Animal Models to Humans.Frontiers in cellular neuroscience · 2021
    Review
  14. Neuroglia in Psychiatric Disorders.Advances in neurobiology · 2021
    Article
  15. Article
  16. Molecules (Basel, Switzerland) · 2020
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Kasum AzimBrain Research Institute, University of Zürich/ETHZ, Zürich, Switzerland.ORCID 0000-0003-3984-4473
Diane AngoninUniv Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, Bron, France.
Guillaume MarcyUniv Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, Bron, France.
Francesca PieropanSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
Andrea RiveraSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
Vanessa DonegaUniv Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, Bron, France.
Claudio CantùIMLS, University of Zurich, Zurich, Switzerland.
Gareth WilliamsWolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London, United Kingdom.
Benedikt BerningerAdult Neurogenesis and Cellular Reprogramming, Institute of Physiological Chemistry, University Medical Centre of the Johannes Gutenberg University Mainz, Germany.
Arthur M ButtSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
Olivier RaineteauBrain Research Institute, University of Zürich/ETHZ, Zürich, Switzerland.
Université Claude Bernard Lyon 1 · FRUniversity of Portsmouth · GBJohannes Gutenberg University Mainz · DEKing's College London · GBUniversity of Zurich · CH

Funding

Biotechnology and Biological Sciences Research Council BB/M029379/1
6 · The paper itself

Abstract

Strategies for promoting neural regeneration are hindered by the difficulty of manipulating desired neural fates in the brain without complex genetic methods. The subventricular zone (SVZ) is the largest germinal zone of the forebrain and is responsible for the lifelong generation of interneuron subtypes and oligodendrocytes. Here, we have performed a bioinformatics analysis of the transcriptome of dorsal and lateral SVZ in early postnatal mice, including neural stem cells (NSCs) and their immediate progenies, which generate distinct neural lineages. We identified multiple signaling pathways that trigger distinct downstream transcriptional networks to regulate the diversity of neural cells originating from the SVZ. Next, we used a novel in silico genomic analysis, searchable platform-independent expression database/connectivity map (SPIED/CMAP), to generate a catalogue of small molecules that can be used to manipulate SVZ microdomain-specific lineages. Finally, we demonstrate that compounds identified in this analysis promote the generation of specific cell lineages from NSCs in vivo, during postnatal life and adulthood, as well as in regenerative contexts. This study unravels new strategies for using small bioactive molecules to direct germinal activity in the SVZ, which has therapeutic potential in neurodegenerative diseases.

Indexed as

Cell LineageTranscriptomeAnimalsComputer SimulationDatabases, GeneticGene Expression RegulationGene Regulatory NetworksGenomicsLateral VentriclesMiceNerve RegenerationNeural Stem CellsNeurogenesisOligodendrogliaSignal TransductionSmall Molecule LibrariesSmall Molecule Libraries

Identifiers

PMID28350803
PMCPMC5370089
OpenAlexW2600710575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.